Jon Snodgres - Feb 16, 2023 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
Chief Financial Officer
Signature
/s/ Kimberly Brown (Attorney in Fact)
Stock symbol
RGEN
Transactions as of
Feb 16, 2023
Transactions value $
-$1,129,400
Form type
4
Date filed
2/17/2023, 03:56 PM
Previous filing
Oct 11, 2022
Next filing
Mar 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Sale -$1.13M -5.65K -16.15% $200.00 29.3K Feb 16, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on September 06, 2022.